May 29, 2019 – An international study involving researchers from UBC Okanagan has shown that MDMA, also known as ecstasy, may be a valuable tool for treating post-traumatic stress disorder (PTSD).  Published recently in Psychopharmacology, the study demonstrated substantial improvements in individuals who had not responded to prior treatments, explains UBCO Associate Professor of psychology Zach Walsh. This is also, he adds, the most comprehensive evaluation of the safety and effectiveness of MDMA-assisted psychotherapy for PTSD.  The response of participants to MDMA-assisted psychotherapy was compared to those who received small doses or non-drug psychotherapy.  “These findings are promising and indicate the needed for larger studies,” says Walsh. “Too many people with PTSD struggle to find effective treatment, and use of MDMA in a supportive environment with trained mental health professionals could be an important addition to our treatment options.”  Ecstasy, also known as Molly, is the nickname for MDMA–a synthetic drug made from a combination of methylenedioxy-methamphetamine.  It is a controlled, illegal drug in Canada classified as a stimulant with hallucinogenic properties.

Full Story @

[ninja-popup ID=12216]